![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/spacer.gif)
(LY-poh-SOH-mul…)
![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/spacer.gif)
| A form of the anticancer drug irinotecan that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than irinotecan alone. Liposomal SN-38 is being studied in the treatment of advanced colorectal cancer and other types of cancer. Liposomal SN-38 blocks the ability of cells to divide and grow. It may stop the growth of tumor cells. It is a type of topoisomerase inhibitor and a type of irinotecan (CPT-11) derivative. Also called SN-38 liposome. |
![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090115184345im_/http://www.cancer.gov/images/spacer.gif) |